Please provide your email address to receive an email when new articles are posted on . Early published reports of cardioneural ablation have shown promise for the relief of autonomically mediated ...
Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...
Atrial fibrillation is a common arrhythmia that affects an estimated 30 million people worldwide. New research shows that catheter ablation, a common cardiovascular procedure, appears no more ...
BOSTON — A novel, selective registry of high-volume electrophysiologists is helping improve treatments for atrial fibrillation by sharing data and evaluating best practices. The Real-World Experience ...
Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...
Biosense Webster, Inc. Announces Catheter Ablation May Be up to 10 Times More Effective Than Standard Drug Therapy Alone at Delaying Progression of Atrial Fibrillation September 02, 2019 04:37 AM ...
For patients who require multisite venous access for catheter ablation procedures, the VASCADE MVP venous vascular closure system (Cardiva Medical) provides a variety of benefits, including a shorter ...
Heart procedure for AFib better than drug therapy for reducing episodes, improving quality of life and symptoms, but not for reducing death or stroke ROCHESTER, Minn. -- Atrial fibrillation is a ...
Stereotaxis announced that it has received European CE Mark approval for its MAGiCâ„¢ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...
The heart is at the center of a complex electrical system. Just like any machine, sometimes the system does not always work correctly. There may be a short circuit. This could lead to an abnormal or ...
Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...